Dr. Hart has over 15 years of leadership experience at pharmaceutical and biotechnology companies
including Bayer, Scios, ViroBay, Inc. and Medivation. Barry has been responsible for identifying and
partnering with CROs to advance pharmaceutical research programs from screening hit to
development. After receiving his Ph.D. from University of Michigan, Barry did post-doctoral work at
University of California, Berkeley.